{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:36:08Z","timestamp":1774352168907,"version":"3.50.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T00:00:00Z","timestamp":1547596800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca corrente RC201702P003967"],"award-info":[{"award-number":["Ricerca corrente RC201702P003967"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210839","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T18:45:23Z","timestamp":1547664323000},"page":"e0210839","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Identification and functional characterization of CD8+ T regulatory cells in type 1 diabetes patients"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9002-3622","authenticated-orcid":true,"given":"Marsha","family":"Pellegrino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"Crin\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela M.","family":"Rosado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3078-9754","authenticated-orcid":true,"given":"Alessandra","family":"Fierabracci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2019,1,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/dmrr.1165","article-title":"The potential of multimer technologies in type 1 diabetes prediction strategies","volume":"27","author":"A Fierabracci","year":"2011","journal-title":"Diabetes Metab. Res. Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"22584","DOI":"10.3390\/ijms160922584","article-title":"Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus","volume":"16","author":"V Perri","year":"2015","journal-title":"Int J Mol Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2010.08.019","article-title":"Recent insights into the role and molecular mechanisms of the autoimmune regulator (AIRE) gene in autoimmunity","volume":"10","author":"A Fierabracci","year":"2011","journal-title":"Autoimmun. Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3389\/fimmu.2017.01578","article-title":"Tregs: Where We Are and What Comes Next?","volume":"8","author":"H Zhao","year":"2017","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2004.11.004","article-title":"CD4+CD25high regulatory T cells inhuman autoimmune diabetes","volume":"24","author":"AL Putnam","year":"2005","journal-title":"J. Autoimmun"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1096\/fj.08-110650","article-title":"CD4+CD25+FoxP3+PD1- regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy","volume":"22","author":"M Saresella","year":"2008","journal-title":"Faseb J"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1172\/JCI87429","article-title":"Neglected for too long?\u2014CD8+ Tregs release NOX2-loaded vesicles to inhibit CD4+ T cells","volume":"126","author":"CT Berger","year":"2016","journal-title":"J Clin Invest"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12967-014-0218-x","article-title":"A microRNA profile of human CD8(+) regulatory T cells and characterization of the effects of microRNAs on Treg cell-associated genes","volume":"12","author":"F Jebbawi","year":"2014","journal-title":"J Transl Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e59545","DOI":"10.1371\/journal.pone.0059545","article-title":"Identification of cytolytic CD161- CD56+ regulatory CD8 T cells in human peripheral blood","volume":"8","author":"D Hu","year":"2013","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fimmu.2015.00171","article-title":"Human and Mouse CD8(+)CD25(+)FOXP3(+) Regulatory T Cells at Steady State and during Interleukin-2 Therapy","volume":"6","author":"G Churlaud","year":"2015","journal-title":"Front Immunol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1182\/blood-2004-03-1214","article-title":"Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation","volume":"104","author":"E Xystrakis","year":"2004","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/cmi.2008.50","article-title":"Generation and regulation of CD8(+) regulatory T cells","volume":"5","author":"L Lu","year":"2008","journal-title":"Cell Mol Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.184.3.1037","article-title":"A truncated T cell receptor repertoire reveals underlying immunogenicity of an antigenic determinant","volume":"184","author":"NK Nanda","year":"1996","journal-title":"Exp Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/08916931003782171","article-title":"CD8(+) T regulatory\/suppressor cells and their relationships with autoreactivity and autoimmunity","volume":"44","author":"G Filaci","year":"2011","journal-title":"Autoimmunity"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.immuni.2010.03.015","article-title":"Reversal of autoimmunity by boosting memory-like autoregulatory T cells","volume":"32","author":"S Tsai","year":"2010","journal-title":"Immunity"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"60201","DOI":"10.18632\/oncotarget.18732","article-title":"Chinese medicine Ginseng and Astragalus granules ameliorate autoimmune diabetes by upregulating both CD4+FoxP3+ and CD8+CD122+PD1+ regulatory T cells","volume":"8","author":"Y Wang","year":"2017","journal-title":"Oncotarget"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1172\/JCI23961","article-title":"TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs","volume":"115","author":"B Bisikirska","year":"2005","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/eji.201242845","article-title":"IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells","volume":"43","author":"A Shameli","year":"2013","journal-title":"Eur J Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e110755","DOI":"10.1371\/journal.pone.0110755","article-title":"Altered B cell homeostasis and toll-like receptor 9-driven response in type 1 diabetes carriers of the C1858T PTPN22 allelic variant: implications in the disease pathogenesis","volume":"9","author":"E Gianchecchi","year":"2014","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2004.08.010","article-title":"Role of LAG-3 in regulatory T cells","volume":"21","author":"CT Huang","year":"2004","journal-title":"Immunity"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.20100209","article-title":"IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells","volume":"207","author":"Y Grinberg-Bleyer","year":"2010","journal-title":"J Exp Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2015.01.001","article-title":"Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients","volume":"58","author":"M Rosenzwajg","year":"2015","journal-title":"J Autoimmun"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/imr.12174","article-title":"Genetic and epigenetic basis of Treg cell development and function: From a FoxP3-centered view to an epigenome-defined view of natural Treg cells","volume":"259","author":"H Morikawa","year":"2014","journal-title":"Immunol. Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.humimm.2010.01.024","article-title":"CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients","volume":"71","author":"G Frisullo","year":"2010","journal-title":"Hum Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/eji.200737529","article-title":"Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation","volume":"38","author":"M Mahic","year":"2008","journal-title":"Eur J Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/ana.21944","article-title":"Role of CD8+ CD25+ Foxp3+ regulatory T cells in multiple sclerosis","volume":"67","author":"J Correale","year":"2010","journal-title":"Ann Neurol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMoa1105143","article-title":"Regulatory T-cell responses to low-dose interleukin-2 in HCV-induced vasculitis","volume":"365","author":"D Saadoun","year":"2011","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"A Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref29","first-page":"11","article-title":"Specific control of immunity by regulatory CD8 T cells","volume":"2","author":"XL Tang","year":"2005","journal-title":"Cell Mol Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1568-9972(02)00065-4","article-title":"CD8+ T suppressor cells are back to the game: are they players in autoimmunity?","volume":"1","author":"G Filaci","year":"2002","journal-title":"Autoimmun Rev"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.transproceed.2012.10.061","article-title":"Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate\/ionomycin and phytohemagglutinin stimulation","volume":"45","author":"H Wang","year":"2013","journal-title":"Transplant Proc"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.humimm.2008.08.282","article-title":"Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28- regulatory T cells","volume":"69","author":"D Fenoglio","year":"2008","journal-title":"Hum Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1385\/IR:29:1-3:303","article-title":"Identification and characterization of CD8+ suppressor T cells","volume":"29","author":"JC Zimring","year":"2004","journal-title":"Immunol Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.20011603","article-title":"Generation of human CD8 T regulatory cells by CD40 ligand-activated plasmacytoid dendritic cells","volume":"195","author":"M Gilliet","year":"2002","journal-title":"J Exp Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0896-8411(03)00118-5","article-title":"Neonatal tolerance to a Th2-mediated autoimmune disease generates CD8+ Tc1 regulatory cells","volume":"21","author":"AC Field","year":"2003","journal-title":"J Autoimmun"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-065X.2001.1820109.x","article-title":"An integrative model of regulation centered on recognition of TCR peptide\/MHC complexes","volume":"182","author":"V Kumar","year":"2001","journal-title":"Immunol Rev"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1084\/jem.20040139","article-title":"In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes","volume":"199","author":"Q Tang","year":"2004","journal-title":"J Exp Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.4049\/jimmunol.1202382","article-title":"Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease","volume":"190","author":"M Wong","year":"2013","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"198","author":"MJ Ansari","year":"2003","journal-title":"J Exp Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"b11823","DOI":"10.1073\/pnas.0505497102","article-title":"Establishment of NOD-Pdcd1-\/- mice as an efficient animal model of type I diabetes","volume":"102","author":"J Wang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.2337\/db12-1475","article-title":"PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes","volume":"62","author":"KE Pauken","year":"2013","journal-title":"Diabetes"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1464-5491.2006.01951.x","article-title":"Phenotypic and genetic analyses of T-cell-mediated immunoregulation in patients with Type 1 diabetes","volume":"23","author":"Y Tsutsumi","year":"2006","journal-title":"Diabet Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/cei.12603","article-title":"Low programmed cell death-1 (PD-1) expression in peripheral CD4(+) T cells in Japanese patients with autoimmune type 1 diabetes","volume":"180","author":"R Fujisawa","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"LM Muller","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.micpath.2017.10.026","article-title":"Mice with type 1 diabetes exhibit increased susceptibility to influenza A virus","volume":"113","author":"C Huo","year":"2017","journal-title":"Microb Pathog"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/039463201102400311","article-title":"Detection of respiratory viruses in the 2009 winter season in Rome: 2009 influenza A (H1N1) complications In children and concomitant type 1 diabetes onset","volume":"24","author":"R Nenna","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"6884","DOI":"10.1128\/JVI.72.8.6884-6887.1998","article-title":"Increased susceptibility of diabetic mice to influenza virus infection: compromise of collectin-mediated host defense of the lung by glucose?","volume":"72","author":"PC Reading","year":"1998","journal-title":"J Virol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/thoraxjnl-2012-203109","article-title":"Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study","volume":"68","author":"D Lau","year":"2013","journal-title":"Thorax"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1006\/clim.2002.5220","article-title":"Impaired primary immune response in type-1 diabetes: results from a controlled vaccination study","volume":"103","author":"N Eibl","year":"2002","journal-title":"Clin Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0008-8749(03)00043-1","article-title":"Impaired primary immune response in type-1 diabetes. Functional impairment at the level of APCs and T-cells","volume":"221","author":"M Spatz","year":"2003","journal-title":"Cell Immunol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T04:21:09Z","timestamp":1720930869000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210839"}},"subtitle":[],"editor":[{"given":"Keun Seok","family":"Seo","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,16]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210839","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,16]]}}}